ArticlePharmacoEconomics2016

Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis.

Matthijs VersteeghPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.